Management of Acute Dystonic Reactions

Introduction to Dystonic Reactions

Acute dystonic reactions are medication-induced extrapyramidal symptoms that can occur with phenothiazine antiemetics, such as prochlorperazine, and require immediate treatment with intravenous anticholinergic medications like diphenhydramine or benztropine, followed by oral anticholinergics if symptoms persist, as recommended by the American College of Medical Toxicology 1

The National Comprehensive Cancer Network recommends considering alternatives with lower risk of extrapyramidal symptoms, such as Granisetron 1-2 mg PO daily, for patients who experience dystonic reactions 1
Dexamethasone 4-8 mg PO/IV daily is suggested as an alternative to prochlorperazine, with a lower risk of extrapyramidal symptoms, by the National Comprehensive Cancer Network 2
For patients requiring phenothiazines who have previously experienced dystonic reactions, pre-medication with diphenhydramine 25-50 mg and consideration of alternative antiemetic classes are recommended, with the use of the lowest effective dose of phenothiazines, as per the National Comprehensive Cancer Network 1
Alternative antiemetics to prochlorperazine include:

Patients should be educated about avoiding prochlorperazine and related phenothiazines in the future, and monitored for complete resolution of symptoms, with documentation of the adverse drug reaction in the patient's medical record and reporting of the adverse event through appropriate pharmacovigilance channels, as recommended by the American College of Medical Toxicology 1
Prochlorperazine is used for antiemetic therapy, including breakthrough nausea/vomiting during chemotherapy, at doses of 10 mg PO/IV every 4-6 hours or 25 mg suppository every 12 hours, and as an adjunctive therapy for migraine management, as per the American Family Physician guidelines and the American Society of Clinical Oncology antiemetics guidelines 5, 6, 4
Typical oral/IV dosing of prochlorperazine is 5-10 mg every 6-8 hours, with a maximum of 40 mg daily, and the suppository form is 25 mg every 12 hours, as per the National Comprehensive Cancer Network guidelines 4
Patients taking prochlorperazine should be monitored for extrapyramidal symptoms, dystonic reactions, CNS depression, anticholinergic effects, and rare cases of drug-induced leukopenia or neutropenia, and used with caution in patients with a history of leukopenia, dementia, glaucoma, or seizure disorder, as per the National Comprehensive Cancer Network guidelines and other references 4, 7